Prognostic Role of Right Ventricular Function in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy

Clinical Cardiology

Volumn 39, Issue 11, 2016, Pages 640-645

  Rapacciuolo, Antonio ^a   Maffè, Stefano ^b   Palmisano, Pietro ^c   Ferraro, Anna ^d   Cecchetto, Antonella ^e   D'Onofrio, Antonio ^f   Solimene, Francesco ^g   Musatti, Paola ^h   Paffoni, Paola ^b   Esposito, Francesca ^a   Parravicini, Umberto ^b   Agresta, Alessia ^a   Botto, Giovanni Luca ⁱ   Malacrida, Maurizio ^j   Stabile, Giuseppe ^k  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SS Trinità Hospital   (Italy)

^c Card G Panico Hospital   (Italy)

^d Rivoli Hospital   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f MONALDI HOSPITAL   (Italy)

^g Casa di Cura Montevergine   (Italy)

^h Cardiology Department   (Italy)

ⁱ Department of Orthopaedics and Traumatology   (Italy)

^j Cardiac Rhythm Management   (Italy)

^k Clinica Mediterranea   (Italy)

more..

Author keywords

cardiac resynchronization therapy; heart failure; remodeling heart failure; right ventricular function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; ITALY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; TRICUSPID VALVE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; TRICUSPID VALVE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84979787986     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22574     Document Type: Article

References (21)

1. van Bommel RJ, Bax JJ, Abraham WT, et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009;30:2470–2477.
2. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–2616.
3. Lin H, Zhou Y, Xu G. Predictors for cardiac resynchronization therapy response: the importance of QRS morphology and left ventricular lead position. Int Heart J. 2014;55:256–263.
4. Palmisano P, Ammendola E, D'Onofrio A, et al. Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study. Clin Cardiol. 2015;38:2–7.
5. Yu CM, Hayes DL. Cardiac resynchronization therapy: state of the art 2013. Eur Heart J. 2013;34:1396–1403.
6. de Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998;32:948–954.
7. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183–188.
8. Field ME, Solomon SD, Lewis EF, et al. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. J Card Fail. 2006;12:616–620.
9. Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281–2329.
10. Stabile G, Bertaglia E, Botto G, et al. Cardiac Resynchronization Therapy Modular Registry: ECG and Rx predictors of response to cardiac resynchronization therapy (NCT01573091). J Cardiovasc Med (Hagerstown). 2013;14:886–893.
11. Kaul S, Tei C, Hopkins JM, et al. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J. 1984;107:526–531.
12. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail. 2001;7:176–182.
13. Ghio S, Freemantle N, Scelsi L, et al. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail. 2009;11:480–488.
14. Beygui F, Furber A, Delépine S, et al. Routine breath-hold gradient echo MRI-derived right ventricular mass, volumes and function: accuracy, reproducibility and coherence study. Int J Cardiovasc Imaging. 2004;20:509–516.
15. Ghio S, Recusani F, Klersy C, et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 2000;85:837–842.
16. Speiser U, Hirschberger M, Pilz G, et al. Tricuspid annular plane systolic excursion assessed using MRI for semi-quantification of right ventricular ejection fraction. Br J Radiol. 2012;85:e716–e721.
17. Kjaergaard J, Petersen CL, Kjaer A, et al. Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI. Eur J Echocardiogr. 2006;7:430–438.
18. Scuteri L, Rordorf R, Marsan NA, et al. Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2009;32:1040–1049.
19. Kjaergaard J, Ghio S, St John Sutton M, et al. Tricuspid annular plane systolic excursion and response to cardiac resynchronization therapy: results from the REVERSE trial. J Card Fail. 2011;17:100–107.
20. Damy T, Ghio S, Rigby AS, et al. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure). J Am Coll Cardiol. 2013;61:2153–2160.
21. Cappelli F, Cristina Porciani M, Ricceri I, et al. Tricuspid annular plane systolic excursion evaluation improves selection of cardiac resynchronization therapy patients. Clin Cardiol. 2010;33:578–582.